4//SEC Filing
Dova Pharmaceuticals, Inc. 4
Accession 0001209191-17-044264
CIK 0001685071operating
Filed
Jul 6, 8:00 PM ET
Accepted
Jul 7, 6:47 AM ET
Size
4.6 KB
Accession
0001209191-17-044264
Insider Transaction Report
Form 4
Laliberte Kevin
Sr. VP, Product Development
Transactions
- Purchase
Common Stock
2017-07-05$17.00/sh+6,200$105,400→ 6,200 total
Documents
Issuer
Dova Pharmaceuticals, Inc.
CIK 0001685071
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001685071
Filing Metadata
- Form type
- 4
- Filed
- Jul 6, 8:00 PM ET
- Accepted
- Jul 7, 6:47 AM ET
- Size
- 4.6 KB